For the optimal viewing experience, please view the HSS Annual report with Microsoft Edge, Google Chrome, Mozilla Firefox or Opera.
ANNUAL REPORT2021Advances in Complex Care


Our dedication to basic and clinical research is helping advance the field on some of the most pressing issues in rheumatology today – from COVID-19 and disparities in care to fundamental questions about the underlying mechanisms of challenging conditions.


A Letter from Lou Bridges

Our Physician-in-Chief shares thoughts on challenges wrought by the pandemic, as well as clinical and research achievements made in 2021.

Read More

FDA Approval of New Lupus Therapy Marks a Milestone

HSS researchers were instrumental in the 2021 FDA approval of anifrolumab, a milestone for systemic lupus erythematosus.

Read More

Managing Rheumatic Patients in the COVID Era

The COVID-19 pandemic provided HSS researchers with a unique opportunity to study the intersection of the illness and rheumatic disease.

Read More

New Treatment Guidelines for Juvenile Idiopathic Arthritis

A team led by HSS clinicians released new guidelines for the treatment of JIA reflecting advances in medications and treatment paradigms.

Read More

Understanding Disparities after Knee Arthroplasty

New research sheds light on potential opportunities to reduce disparities in outcomes between Blacks and whites following total knee arthroplasty.

Read More

A Letter from HSS Medical Leadership

Hear from our medical and research leadership on the evolution of complex care at HSS in 2021.

Read More
Rotation Icon
Please rotate your device
We support landscape portrait mode only